logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (iii) All outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge knownAge not known
Opiates5.741.727.712.96.43.11.41.122.314872032271
Cocaine5.642.325.612.57.33.81.91.022.5582469371
Stimulants12.756.016.86.53.61.70.81.720.4103042655
Hypnotics and sedatives11.126.616.413.210.77.56.18.526.950221509
Hallucinogens9.353.921.89.63.21.30.70.120.1685262
Volatile substances19.174.52.41.40.70.50.40.917.7954310
Cannabis 36.952.27.12.00.90.40.20.417.06021422404
Other substances 20.540.013.76.25.73.82.08.123.524831222
Total12.844.422.110.25.32.71.31.221.228662870004

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR 

 Last data available from Spain and Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011